Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease.
about
Antiplatelet agents and anticoagulants for hypertensionMultiple risk factor interventions for primary prevention of coronary heart diseaseMultiple risk factor interventions for primary prevention of coronary heart diseaseAntiplatelet agents and anticoagulants for hypertensionDebate: does it matter how you lower blood pressure?Loss of circadian rhythm of blood pressure following acute stroke2013 Korean Society of Hypertension guidelines for the management of hypertension. Part II-treatments of hypertensionAn update on renal artery denervation and its clinical impact on hypertensive diseaseTargeting G protein coupled receptor-related pathways as emerging molecular therapiesWhat is an appropriate blood pressure goal for the elderly: review of recent studies and practical recommendationsAntithrombotic therapy in hypertension: a Cochrane Systematic reviewA novel method to adjust efficacy estimates for uptake of other active treatments in long-term clinical trialsTight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study GroupWhy not prescribe the best drugs for hypertension now?Fixed combination of zofenopril plus hydrochlorothiazide in the management of hypertension: a review of available data.Regression of left ventricular hypertrophy; what are appropriate therapeutic objectives?Adherence level of antihypertensive agents in coronary artery disease.The UK prospective diabetes study (UKPDS): clinical and therapeutic implications for type 2 diabetes.Major inducing factors of hypertensive complications and the interventions required to reduce their prevalence: an epidemiological study of hypertension in a rural population in China.The antihypertensive efficacy of losartan and amlodipine assessed with office and ambulatory blood pressure monitoring. Canadian Cozaar Hyzaar Amlodipine Trial Study GroupDo we need more than just powerful blood pressure reductions? New paradigms in end-organ protectionAngiotensin-converting enzyme inhibitors will help in improving stroke outcome if given immediately after strokeA critique of hypertension treatment trials and of their evaluation.Inflation in epidemiology: "the proof and measurement of association between two things" revisited.The impact of interventions by pharmacists in community pharmacies on control of hypertension: a systematic review and meta-analysis of randomized controlled trialsSafety and effectiveness of a fixed-dose combination of olmesartan, amlodipine, and hydrochlorothiazide in clinical practice.A new fixed-dose combination for added blood pressure control: telmisartan plus hydrochlorothiazide.Hypertension awareness, treatment and control in Africa: a systematic review.Clinical trials and tribulations.Secular changes in blood pressure in childhood, adolescence and young adulthood: systematic review of trends from 1948 to 1998.The profile of risk factors and in-patient outcomes of stroke in Kumasi, GhanaThe effect on ambulatory blood pressure of working under favourably and unfavourably perceived supervisors.Trends in hypertension epidemiology in India.Current and future concepts in stroke prevention.American, British and European recommendations for statins in the primary prevention of cardiovascular disease applied to British men studied prospectively.New evidence in hypertension and hyperlipidaemia.Antihypertensive medications for risk reduction of first and recurrent ischemic stroke.Uncontrolled Hypertension and Its Determinants in Patients with Concomitant Type 2 Diabetes Mellitus (T2DM) in Rural South Africa.Novel angiotensin-converting enzyme inhibitory peptides from caseins and whey proteins of goat milkHypertension and its management: a problem in need of new treatment strategies.
P2860
Q24234617-FFB5A574-BFAA-443D-8185-0076CCAD4A46Q24234642-51DBE6E8-D0B1-44DC-A2DE-62DFCE5F0B74Q24243941-FF7B7349-7FD4-4233-8C0B-1AB60F0868B3Q24246637-E3C13D44-15E1-4E56-B704-71C116EE0BDFQ24792999-6DFD6386-634A-4BC1-BF96-106735135707Q24794382-82E899F2-5AFF-4F17-8A03-6A0CECA1B6A9Q26764784-75A186EB-953D-4D24-BEE0-C857AC5BCBBEQ26780078-F5CD1AED-0F2D-45E6-8490-81DA03677BBAQ26829964-98C25271-C913-4AA3-8333-84A1C5173CA2Q26864349-1FC5FE26-F825-4F29-AE56-26461F836808Q28213879-6471D021-579C-4071-9E86-EA2F4BAA89D5Q28472432-2E79DD4D-9515-4E6B-836F-2DF016319DCCQ29617736-4D524C60-2947-4D86-8328-6AE5BE8FC69AQ30333019-04675230-0B26-4AF1-8AEE-DA629F0A1D84Q31102886-9C3393E6-E0E9-45B6-9175-F7BC4C3AD4E3Q33586708-B1D46209-D03D-4AFD-80AE-DF0BAA3E91ACQ33696605-52A67B47-AA5E-4245-9CA4-B7B2A592AF55Q33792394-5F4B0768-4BB5-4238-A3F6-E00AF2A7C71EQ33898726-87CBBB89-B06A-426B-AF6F-863AE0CAB7E3Q34029556-D83B325A-4837-4F26-B93A-269A59326094Q34068728-AD415A0D-C009-4577-9A67-F15D09191FD5Q34311942-05FA14BD-065F-4B69-81E4-3D8459B8C2BBQ34328239-435E5915-E4A9-4F8B-BF92-61D9BFB4EB8AQ34384887-336EC6CD-CD9D-4650-B471-D167B585C4BFQ34635492-E509FA27-A9DC-4F8C-BB76-44362E575007Q34764232-1CFF047F-8A4F-4F45-B868-2641E76F3F90Q34864754-4FAF6EE6-35E1-4554-ABCC-3CC4350C7623Q34894104-D35E8CBC-82A3-42B4-9BC1-F0785F7E0687Q34941150-72ED42FB-95AB-4293-A26C-09343057F471Q34990964-659FF92F-3B6B-4931-A1F6-2C09DD2541B5Q35104615-0BF116EB-F5C9-41CA-9DE2-7311D302BCA1Q35499071-84FCE3CF-DAD8-4311-A7A2-8605F56B71D0Q35632398-2CD129CE-1EF0-4037-A91F-F85A6075809DQ35722818-75AF53DB-E042-464F-99F1-E133C20A0F5DQ35772358-7A01D329-5005-4D1C-9C5A-BFE7A794ADACQ35774824-8ED3EA66-70EA-4C3E-9D95-69481EF04ACCQ35925696-933ED661-3477-4435-8F32-08C6CB6CCB03Q35940660-1F908B0C-0887-4E36-B095-7E48CC22426BQ36239923-223FCC31-A9EE-4FC8-A9A8-A06A8B949C92Q36697570-3A8AA520-8D37-40D7-9A9F-99972CE76C8F
P2860
Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh
1994年學術文章
@zh-hant
name
Blood pressure, antihypertensi ...... and of coronary heart disease.
@en
type
label
Blood pressure, antihypertensi ...... and of coronary heart disease.
@en
prefLabel
Blood pressure, antihypertensi ...... and of coronary heart disease.
@en
P1476
Blood pressure, antihypertensi ...... and of coronary heart disease.
@en
P2093
P304
P356
10.1093/OXFORDJOURNALS.BMB.A072892
P577
1994-04-01T00:00:00Z